GenetikSignal Company
GenetikSignal was founded in 2011 as an anti-aging biotechnology company focusing on the mTOR signal transduction pathway. With the recent development of rapamycin analogs Everolimus and Temsirolimus targeting cell proliferation and FDA approval for metastatic breast cancer, there is excitement in the development of targeted therapies in this pathway for age-related diseases such as cancer and neurodegenerative diseases.
Technology:
Skin care preparations
Industry:
Skin care
Headquarters:
Rockville, USA
Founded Date:
01.08.2011
Employees Number:
N/A
Funding Status:
N/A
Total Funding:
$0
Estimated Revenue:
$0
Last Funding Date:
N/A
Last Funding Type:
N/A
Register and Claim Ownership